553 related articles for article (PubMed ID: 26255201)
1. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
3. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
[TBL] [Abstract][Full Text] [Related]
5. miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression.
Wang H; Wang Z; Wang Y; Li X; Yang W; Wei S; Shi C; Qiu J; Ni M; Rao J; Cheng F
J Cell Mol Med; 2021 Aug; 25(15):7381-7394. PubMed ID: 34272822
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
[TBL] [Abstract][Full Text] [Related]
7. Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor γ.
Jiang Y; Wang S; Zhao Y; Lin C; Zhong F; Jin L; He F; Wang H
FASEB J; 2015 May; 29(5):1830-41. PubMed ID: 25609425
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis.
Tao L; Wu L; Zhang W; Ma WT; Yang GY; Zhang J; Xue DY; Chen B; Liu C
Life Sci; 2020 Jul; 253():117572. PubMed ID: 32201276
[TBL] [Abstract][Full Text] [Related]
9. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
[TBL] [Abstract][Full Text] [Related]
12. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
[TBL] [Abstract][Full Text] [Related]
13. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
14. β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells.
Qian J; Niu M; Zhai X; Zhou Q; Zhou Y
Pharmacol Res; 2012 Sep; 66(3):219-25. PubMed ID: 22706027
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
Sun J; Zhang H; Li L; Yu L; Fu L
Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
[TBL] [Abstract][Full Text] [Related]
16. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a.
Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ
J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.
Ma L; Yang X; Wei R; Ye T; Zhou JK; Wen M; Men R; Li P; Dong B; Liu L; Fu X; Xu H; Aqeilan RI; Wei YQ; Yang L; Peng Y
Cell Death Dis; 2018 Jun; 9(7):718. PubMed ID: 29915227
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ.
Luo H; Zhu H; Zhou B; Xiao X; Zuo X
Mod Rheumatol; 2015 Jul; 25(4):595-602. PubMed ID: 25547017
[TBL] [Abstract][Full Text] [Related]
19. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells.
Li ZJ; Ou-Yang PH; Han XP
Cell Signal; 2014 Jan; 26(1):141-8. PubMed ID: 24100264
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7.
Zhu J; Zhang Z; Zhang Y; Li W; Zheng W; Yu J; Wang B; Chen L; Zhuo Q; Chen L; Zhang J; Liu J
Biochem Biophys Res Commun; 2018 Jan; 496(1):176-183. PubMed ID: 29307832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
